A retrospective study (2001–2017) of acute and chronic morbidity and mortality associated with Staphylococcus aureus bacteraemia in a tertiary neonatal intensive care unit
- 122 Downloads
Staphylococcus aureus bacteraemia (SAB) in NICU patients can cause significant morbidity and mortality.
To review early and late neonatal SAB with regard to risk factors, treatment, acute complications and long-term outcomes.
A retrospective study of laboratory confirmed SAB over a 16-year period (November 2001–January 2017) in a tertiary neonatal unit in Ireland.
A total of 74 neonates (MSSA n = 72, MRSA n = 2) were identified; 8.1% (n = 6) early sepsis, 91.8% (n = 68) late sepsis. Low birth weight neonates (born weighing less than 2500 g) 80% (n = 59). Median age to bacteraemia 11 days post-delivery (range = 0–100 days); median onset early sepsis 1.5 days versus late sepsis 12 days. Complications of SAB; cellulitis n = 17, pneumonia n = 12, necrotising enterocolitis n = 7, thromobophlebitis n = 5, skin abscess formation n = 4, osteomyelitis n = 3, endocarditis n = 1. Late SAB mortality 6.4% (n = 3).
Preterm and low birth weight infants were at highest risk of SAB. Only a small proportion of affected children had long-term clinical sequelae on follow-up. The high rate of recurrence and breakthrough bacteraemia suggests that early implementation of a targeted anti-staphylococcal antimicrobial regimen may be of particular benefit.
KeywordsNeonatal intensive care unit Outcomes Staphylococcus aureus bloodstream infection
Compliance with ethical standards
Ethical approval was received from the local ethics committee to conduct this study.
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.Santos De Oliveira R, Ferreira Pinho V, Flavio Gurjao Madureira J et al (2007) Brain abcess in a neonate an unusual presentation. Childs Nerv Syst 23:129–142Google Scholar
- 9.Kempley S, Kapellou O, McWiliams A et al (2015) Antibiotic treatment duration and prevention of complications in neonatal Staphylococcus Aureus bacteremia. JHI 91:129–135Google Scholar
- 11.Bizarro MJ, Raskind C, Baltimore RS et al (2005) Seventy five years of neonatal sepsis at Yale 1928-2003. Pediatrics 116(3):592–602Google Scholar
- 12.Johnson AP, Sharland M, Goodall CM, Blackburn R, Kearns AM, Gilbert R, Lamagni TL, Charlett A, Ganner M, Hill R, Cookson B, Livermore D, Wilson J, Cunney R, Rossney A, Duckworth G (2010) Enhanced surveillance of methicillin resistant Staphylococcus Aureus bacteremia in children in the UK and Ireland. Arch Dis Child 95:781–785CrossRefPubMedGoogle Scholar
- 15.Thaden JT, Ericson JE, Cross H, Bergin SP, Messina JA, Fowler VG Jr, Benjamin DK Jr, Clark RH, Hornik CP, Smith PB, Antibacterial Resistance Leadership Group (2015) Survival benefit for Staphylococcus Aureus bloodstream infections in infants. Paediatr Infect Dis J 34(11):1175–1179CrossRefGoogle Scholar